1 |
Drake L, Hordinsky M, Fieldler V, Swinehart J, Unger WP, Cotterill PC, Thiboutot DM, Lowe N, Jacobson C, Whiting D, Stieglitz S, Kraus SJ, Griffin EI, Weiss D, Carrington P, Gencheff C, Cole GW, Pariser DM, Epstein ES, Tanaka W, Dallob A, Vandormael K, Geissler L, Waldstreicher J: The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. J Am Acad Dermatol 41: 550, 1999
|
2 |
Yang JS, Lavker RM, Sun TT: Upper human hair follicle contains a subpopulation of keratinocytes with superior in vitro proliferative potential. J Invest Dermatol 101: 652, 1993
DOI
ScienceOn
|
3 |
Sasmaz S, Arican O: Comparison of azelaic acid and anthralin for the therapy of patchy alopecia areata: a pilot study. Am J Clin Dermatol 6: 403, 2005
DOI
ScienceOn
|
4 |
Tsuji Y, Denda S, Soma T, Raftery L, Momoi T, Hibino T: A potential suppressor of TGF- delays catagen progression in hair follicles. J Investig Dermatol Symp Proc 8: 65, 2003
|
5 |
Jiang H, Yamamoto S, Kato R: Induction of anagen in telogen mouse skin by topical application of FK506, a potent immunosuppressant. J Invest Dermatol 104: 523, 1995
DOI
ScienceOn
|
6 |
Frampton JE, Wagstaff AJ: Azelaic acid 15% gel in the treatment of papulopustular rosacea. Am J Clin Dermatol 5: 57, 2004
DOI
ScienceOn
|
7 |
Yamamoto S, Jiang H, Kato R: Stimulation of hair growth by topical application of FK506, a potent immunosuppressive agent. J Invest Dermatol 102: 160, 1994
DOI
ScienceOn
|
8 |
Paus R, Stenn KS, Link RE: Telogen skin contains an inhibitor of hair growth. Br J Dermatol 122: 777, 1990
DOI
ScienceOn
|
9 |
Messenger AG: The control of hair growth and pigmentation. New York, McGraw-Hill, 1994, p 39
|
10 |
Lurie R, Ben-Amitai D, Laron Z: Laron syndrome (primary growth hormone insensitivity): a unique model to explore the effect of insulin-like growth factor 1 deficiency on human hair. Dermatology 208: 314, 2004
DOI
ScienceOn
|
11 |
Mitsui S, Ohuchi A, Hotta M, Tsuboi R, Ogawa H: Genes for a range of growth factors and cyclin- dependent kinase inhibitors are expressed by isolated human hair follicles. Br J Dermatol 137: 693, 1997
DOI
ScienceOn
|
12 |
Krautheim A, Gollnick H: Transdermal penetration of topical drugs used in the treatment of acne. Clin Pharmacokinet 42: 1287, 2003
DOI
ScienceOn
|
13 |
Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JM, Tschen EH, Trancik RJ: A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol 47: 377, 2002
DOI
ScienceOn
|
14 |
Dargie HJ, Dollery CT, Daniel J: Minoxidil in resistant hypertension. Lancet 2: 515, 1977
|